Cell cycle effects of gemcitabine

International Journal of Cancer

Volumn 93, Issue 3, 2001, Pages 401-408

  Cappella, Paolo ^a   Tomasoni, Daniela ^a   Faretta, Mario ^a   Lupi, Monica ^a   Montalenti, Francesco ^a   Viale, Federica ^a   Banzato, Fabio ^a   D'Incalci, Maurizio ^a   Ubezio, Paolo ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Apoptosis; Cell cycle; Cell proliferation; Chemotherapy; Flow cytometry; Gemcitabine

Indexed keywords

CISPLATIN; DNA; GEMCITABINE; SULFORHODAMINE B;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL KINETICS; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA SYNTHESIS; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL;

ANTIMETABOLITES, ANTINEOPLASTIC; CELL CYCLE; CELL SURVIVAL; DEOXYCYTIDINE; DNA REPLICATION; DNA, NEOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLOW CYTOMETRY; HUMANS; OVARIAN NEOPLASMS; S PHASE; TUMOR CELLS, CULTURED;

EID: 0035426936     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1351     Document Type: Article

References (21)

1. Gemcitabine: A cytidine analogue active against solid tumors
2. Gemcitabine - A major advance?
3. Evaluation of the antitumor activity of gemcitabine (2′,2 ′-difluoro2′-deoxycytidine)
4. Gemcitabine - A safety review
5. Action of 2′,2′-difluorodeoxycytidine on DNA synthesis
6. Pharmacologically directed design of the dose rate and schedule of 2′,2′-difluorodeoxycytidine (Gemcitabine) administration in leukemia
7. Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine
8. Method for kinetic analysis of drug-induced cell cycle perturbations
9. Increasing 1-beta-D-arabinofuranosylcytosine efficacy by scheduled dosing intervals based on direct measurements of bone marrow cell kinetics
10. Cytometry in cell necrobiology: Analysis of apoptosis and accidental cell death (necrosis)
11. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays
12. New colorimetric cytotoxicity assay for anticancer-drug screening
13. Simulating cancer-cell kinetics after drug treatment: Application to cisplatin on ovarian carcinoma
14. Measuring the complexity of cell cycle arrest and killing of drugs: Kinetics of phase-specific effects induced by taxol
15. The new cytidine analog gemcitabine (gem) has schedule- rather than dose-related activity in human tumor xenografts
16. Schedule-dependent antitumor effect of gemcitabine in in vivo model system
17. Enhancement of tumor radioresponse in vivo by gemcitabine
18. Fludarabine- and gemcitabine-induced apoptosis: Incorporation of analogs into DNA is a critical event
19. Comparison of the cellular pharmacokinetics and toxicity of 2′,2′-difluorodeoxycytidine and 1-beta-D-arabinofuranosylcytosine
20. Radiosensitizing potential of gemcitabine (2′,2′-difluoro-2′-deoxycytidine) within the cell cycle in vitro
21. Cell cycle arrest in ovarian cancer cell lines does not depend on p53 status upon treatment with cytostatic drugs